CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2025)

CollPlant Biotechnologies filings provide 9 years of Gross Profit readings, the most recent being -$132000.0 for Q4 2025.

  • On a quarterly basis, Gross Profit fell 22.22% to -$132000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.0 billion, a 630391.62% decrease, with the full-year FY2025 number at $1.5 million, up 238.38% from a year prior.
  • Gross Profit hit -$132000.0 in Q4 2025 for CollPlant Biotechnologies, up from -$192000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $13.6 million in Q1 2021 to a low of -$7.0 billion in Q2 2025.
  • Median Gross Profit over the past 5 years was -$143500.0 (2022), compared with a mean of -$448.9 million.
  • Biggest five-year swings in Gross Profit: plummeted 73882626.78% in 2021 and later surged 41504.35% in 2023.
  • CollPlant Biotechnologies' Gross Profit stood at -$238000.0 in 2021, then skyrocketed by 98.32% to -$4000.0 in 2022, then crashed by 11750.0% to -$474000.0 in 2023, then surged by 77.22% to -$108000.0 in 2024, then dropped by 22.22% to -$132000.0 in 2025.
  • The last three reported values for Gross Profit were -$132000.0 (Q4 2025), -$192000.0 (Q3 2025), and -$7.0 billion (Q2 2025) per Business Quant data.